No Data
Express News | Sarepta Therapeutics Shares Are Trading Lower. The Company Reported Q3 Financial Results
Sarepta Therapeutics: Q3 Earnings Snapshot
Earnings Flash (SRPT) SAREPTA THERAPEUTICS Posts Q3 Revenue $467.2M
Sarepta Therapeutics | 10-Q: Quarterly report
Sarepta Therapeutics Q3 2024 Adj. EPS $0.62 Beats $(0.13) Estimate, Sales $467.172M Beat $409.297M Estimate.
Sarepta Therapeutics Announces Third Quarter 2024 Financial Results and Recent Corporate Developments